Non-Invasive Spinal Stimulation

Non-invasive spinal stimulation refers to the use of new and emerging technologies to improve motor control acquisition in children and adults through the neuroplasticity of the spinal cord. Recent studies and findings provide hope for improved outcomes for children with cerebral palsy, spina bifida, and spinal cord injuries.

​

Non-invasive spinal stimulation may improve ease of mobility, decrease spasticity, increase gait speed, increase balance and energy, vision processing, oral motor function, and overall proprioceptive input. If you are interested in reading more on Dr. Reggie Edgerton's and Dr. Susan Hastings' pioneering work in the field of spinal stim, click here.

 

As a strategic advisor for SpineX, a clinical-stage bioelectric MedTech company working to bring the first non-invasive spinal stimulation device (SCiPTM) to market for the pediatric population, Kristin provides therapeutic treatment for research purposes at SpineX’s Los Angeles clinic. She has provided treatment in studies ranging from 6 to 20 weeks, studying the effectiveness of the SCiP device in the pediatric (with and without SDR surgery intervention) population and in the adult population. Go to ___ (ill insert link) to learn more about Logan, a participant treated with 8 weeks of SCiP therapy. Kristin knows that the SCiPTM will change the lives of so many adults and children living with cerebral palsy and is proud to support the SpineX team to receive FDA approval and bring the product to market. If you or someone you know is interested in participating in a clinical trial, go to SpineX.co to learn more about hospital trials in your area.